Amarin Corporation plc
AMARIN CORP PLC\UK (Form: 8-K, Received: 12/16/2016 16:09:30)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 14, 2016

 

 

Amarin Corporation plc

(Exact name of registrant as specified in its charter)

 

 

 

England and Wales   0-21392   Not applicable

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

2 Pembroke House, Upper Pembroke Street 28-32, Dublin 2, Ireland   Not applicable
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: +353 1 6699 020

Not Applicable

Former name or former address, if changed since last report

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Resignation of James Healy.

On December 14, 2016, James I. Healy, M.D., Ph.D. informed the Board of Directors of Amarin Corporation plc (the “Company”) of his resignation from the Board of Directors, effective December 20, 2016. Dr. Healy’s resignation was not caused by any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. A copy of Dr. Healy’s resignation letter is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit
No.

  

Description

99.1    Resignation Letter of Dr. James I. Healy, dated December 14, 2016

*    *    *


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 16, 2016     Amarin Corporation plc
    By:  

/s/ John Thero

      John Thero
      President and Chief Executive Officer

Exhibit 99.1

Amarin Corporation plc

One New Change

London EC4M 9AF, England

Dear Sirs,

 

Re:    

 

Resignation from directorship of Amarin Corporation plc

I write to confirm my resignation, effective as of 12:00 a.m. (Eastern time) on December 20, 2016, from the board of directors (including any committees thereof) of Amarin Corporation plc, a public limited company incorporated under the laws of England and Wales (“Amarin”), and all positions as an officer or member of the board of directors (including any committees thereof) of any subsidiary of Amarin.

I instruct and irrevocably authorize you, as my agent, to convey and effect such resignation by sending a copy of this letter to the board of directors of Amarin.

I further confirm that I have no cause of action against Amarin or any of its associated or subsidiary companies or its or their respective officers or employees, arising from or connected with the above resignation.

It has been a pleasure to serve on the board of Amarin and I wish the company much success and continued progress.

 

Yours faithfully,

LOGO

James I. Healy, M.D., Ph.D.

Date: December 14, 2016